These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 11226131)

  • 1. Analysis of the muscarinic receptor subtype mediating inhibition of the neurogenic contractions in rabbit isolated vas deferens by a series of polymethylene tetra-amines.
    Budriesi R; Cacciaguerra S; Toro RD; Bolognesi ML; Chiarini A; Minarini A; Rosini M; Spampinato S; Tumiatti V; Melchiorre C
    Br J Pharmacol; 2001 Mar; 132(5):1009-16. PubMed ID: 11226131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of field stimulation-induced contractions of rabbit vas deferens by muscarinic receptor agonists: selectivity of McN-A-343 for M1 receptors.
    Davies RH; Scholes HE; Virdi S; Broadley KJ
    J Pharm Pharmacol; 2001 Apr; 53(4):487-96. PubMed ID: 11341365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional determination of McN-A-343 affinity for M1 muscarinic receptors.
    Micheletti R; Schiavone A
    J Pharmacol Exp Ther; 1990 Apr; 253(1):310-4. PubMed ID: 1691785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Universal template approach to drug design: polyamines as selective muscarinic receptor antagonists.
    Bolognesi ML; Minarini A; Budriesi R; Cacciaguerra S; Chiarini A; Spampinato S; Tumiatti V; Melchiorre C
    J Med Chem; 1998 Oct; 41(21):4150-60. PubMed ID: 9767650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presynaptic muscarinic receptors mediating inhibition of neurogenic contractions in rabbit vas deferens are of the ganglionic M1-type.
    Eltz M; Gmelin G; Wess J; Strohmann C; Tacke R; Mutschler E; Lambrecht G
    Eur J Pharmacol; 1988 Dec; 158(3):233-42. PubMed ID: 2472963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of selectivity of muscarinic antagonists for M1 and M2 receptors in rabbit isolated vas deferens.
    Eltze M
    Pharmacology; 1988; 37 Suppl 1():40-7. PubMed ID: 2467317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the prejunctional muscarinic receptors mediating inhibition of evoked release of endogenous noradrenaline in rabbit isolated vas deferens.
    Grimm U; Fuder H; Moser U; Bümert HG; Mutschler E; Lambrecht G
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Jan; 349(1):1-10. PubMed ID: 8139696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathways involved in muscarinic M1 and M2 receptor stimulation in rabbit vas deferens.
    Eltze M
    Eur J Pharmacol; 1994 Sep; 263(1-2):31-7. PubMed ID: 7529712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselective recognition of the enantiomers of phenglutarimide and of six related compounds by four muscarinic receptor subtypes.
    Waelbroeck M; Lazareno S; Pfaff O; Friebe T; Tastenoy M; Mutschler E; Lambrecht G
    Br J Pharmacol; 1996 Dec; 119(7):1319-30. PubMed ID: 8968538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of brucine, a plant alkaloid, on M(1) muscarinic receptors and alpha(1)-adrenoceptors in the rabbit vas deferens preparation.
    Bradley KN; Rowan EG; Harvey AL
    Toxicon; 2001 Apr; 39(4):581-7. PubMed ID: 11024498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscarinic M1 receptor agonist actions of muscarinic receptor agonists in rabbit vas deferens.
    Shannon HE; Sawyer BD; Bemis KG; Bymaster FP; Health I; Mitch CH; Ward JS
    Eur J Pharmacol; 1993 Feb; 232(1):47-57. PubMed ID: 8458395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycopyrronium bromide blocks differentially responses mediated by muscarinic receptor subtypes.
    Fuder H; Meincke M
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Jun; 347(6):591-5. PubMed ID: 7689704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the muscarinic receptor subtype(s) mediating contraction of the guinea-pig lung strip and inhibition of acetylcholine release in the guinea-pig trachea with the selective muscarinic receptor antagonist tripitramine.
    Roffel AF; Davids JH; Elzinga CR; Wolf D; Zaagsma J; Kilbinger H
    Br J Pharmacol; 1997 Sep; 122(1):133-41. PubMed ID: 9298539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The design and pharmacology of novel selective muscarinic agonists and antagonists.
    Lambrecht G; Gross J; Hacksell U; Hermanni U; Hildebrandt C; Hou X; Moser U; Nilsson BM; Pfaff O; Waelbroeck M
    Life Sci; 1995; 56(11-12):815-22. PubMed ID: 10188780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscarinic receptor subtypes in the bisected vas deferens of the rat.
    Miranda HF; Duran E; Fernandez E; Pinardi G
    Gen Pharmacol; 1995 Mar; 26(2):387-91. PubMed ID: 7590092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of imidafenacin (KRP-197/ONO-8025), a new anti-cholinergic agent, on muscarinic acetylcholine receptors. High affinities for M3 and M1 receptor subtypes and selectivity for urinary bladder over salivary gland.
    Kobayashi F; Yageta Y; Segawa M; Matsuzawa S
    Arzneimittelforschung; 2007; 57(2):92-100. PubMed ID: 17396619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the mechanism for the relaxation of rat duodenum mediated via M1 muscarinic receptors.
    Hamrouni AM; Gudka N; Broadley KJ
    Auton Autacoid Pharmacol; 2006 Jul; 26(3):275-84. PubMed ID: 16879493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscarinic subtype affinity and functional activity profile of 1-methyl-2-(2-methyl-1,3-dioxolan-4-yl)pyrrolidine and 1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine derivatives.
    Dei S; Angeli P; Bellucci C; Buccioni M; Gualtieri F; Marucci G; Manetti D; Matucci R; Romanelli MN; Scapecchi S; Teodori E
    Biochem Pharmacol; 2005 Jun; 69(11):1637-45. PubMed ID: 15896343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo.
    Hegde SS; Choppin A; Bonhaus D; Briaud S; Loeb M; Moy TM; Loury D; Eglen RM
    Br J Pharmacol; 1997 Apr; 120(8):1409-18. PubMed ID: 9113359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selectivity profile of muscarinic toxin 3 in functional assays of cloned and native receptors.
    Olianas MC; Ingianni A; Maullu C; Adem A; Karlsson E; Onali P
    J Pharmacol Exp Ther; 1999 Jan; 288(1):164-70. PubMed ID: 9862767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.